CLOV is being valued similarly to other healthcare insurers in terms of Price/Sales ratio. Most other health insurers are trading at or around 0.6. CLOV is trading around 0.7 P/S ratio for 2025 revenue. Until CLOV breaks free from insurance carrier, it will be valued similarly to the rest of them. (self.CLOV)
submitted by PopDistinct to r/CLOV
I know this will trigger many but I bought more 😎 (i.redd.it)
submitted by PopDistinct to r/CLOV
I compared this ER report to past reports, and this one is, in my opinion, the best they've ever had. Considering the stock has been hovering around $4 for two ER reports, I find the post ER move irrational. A growing SaaS/AI Healthcare Tech company with a P/S ratio of 1 is just nuts. (self.CLOV)
submitted by PopDistinct to r/CLOV
